Canadian biopharmaceuticals co-innovation mission to Germany – November 3 to 8, 2024

Sector: Biopharmaceuticals

Subsectors: 

• Advanced therapies (cell and gene therapies; CAR-T and CAR-NK cells, etc.)
• Drug delivery (LNPs, viral vectors) with genetic medicine payloads (mRNA, siRNA, CRISPR, etc.)
• Antibody-based therapeutics and other targeted biologics
• Companion diagnostics
• Biomanufacturing enabling technologies for the therapy and vaccine types listed above

Open to: Small and medium-sized enterprises

Deadline to apply: June 14, 2024

More information: Consult the detailed request for expression of interest

Related program: Canadian International Innovation Program